AGM/EGMJun 4, 2026, 04:12 PM
Lipocine Shareholders Approve Stock Plan Amendment, Elect Directors
AI Summary
Lipocine Inc. shareholders approved the Sixth Amended and Restated 2014 Stock and Incentive Plan at their annual general meeting on June 3, 2026. The amendment increases individual award limits from 25,000 to 100,000 shares and the total authorized shares for issuance under the plan by 400,000 to 1,000,000 shares. Additionally, shareholders elected four directors, ratified Tanner LLC as the independent auditor, and approved the advisory vote on executive compensation.
Key Highlights
- Shareholders approved the Sixth Amended and Restated 2014 Stock and Incentive Plan.
- Individual award limits under the plan increased from 25,000 to 100,000 shares.
- Authorized shares for the plan increased by 400,000 to a total of 1,000,000 shares.
- Four directors were elected for a one-year term.
- Tanner LLC was ratified as the independent registered public accounting firm.
- Advisory vote on executive compensation was approved with 1,626,360 votes For.
Price Impact
More from LPCN